Invesco Ltd. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 33 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$376,000
+1.3%
375,0000.0%0.00%
Q2 2021$371,000
-4.4%
375,0000.0%0.00%
Q1 2021$388,000
+9.9%
375,0000.0%0.00%
Q4 2020$353,000
+4.4%
375,0000.0%0.00%
Q3 2020$338,000
-23.0%
375,000
-25.0%
0.00%
Q2 2020$439,000
+6.3%
500,0000.0%0.00%
Q1 2020$413,000
-4.4%
500,0000.0%0.00%
Q4 2019$432,000
+3.6%
500,0000.0%0.00%
Q3 2019$417,000
-61.4%
500,000
-60.0%
0.00%
Q2 2019$1,079,0001,250,0000.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 40,000,000$38,988,0001.44%
Penn Mutual Asset Management, LLC 1,204,000$1,174,0001.36%
TFG Asset Management GP Ltd 21,600,000$21,148,0000.96%
PALISADE CAPITAL MANAGEMENT, LP 10,006,000$9,832,0000.23%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,431,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 20,353,000$19,882,0000.21%
Wellesley Asset Management 2,304$2,245,0000.15%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 10,000,000$9,719,0000.12%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,942,0000.11%
Cutler Capital Management, LLC 300,000$291,0000.10%
View complete list of LIGAND PHARMACEUTICALS INC shareholders